CLINICAL_TRIALS
trial_result
· 2013-12-18
Clinical Trial Update: Pilot Study of Growth Hormon to Treat SMA Typ II and III [Phase 2]
Summary
A Phase 2 pilot trial evaluating growth hormone (somatropin) for spinal muscular atrophy type II and III has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital Freiburg | Conditions: Muscular Atrophy, Spinal | Phase 2 | Status: COMPLETED